SIGN UP
LOG IN
C
CYCC
Cyclacel Pharma
0.26
-0.05-15.01%After Hours: 0.2540 -0.00 -1.63%19:59 04/30 EDT
OPEN/PREV CLOSE0.2483/0.3038
TODAY RANGE0.2370-0.2760
VOL4.76M
MARKET CAP63.61M
52 WEEK RANGE0.0809-1.897
AVG VOL (3M)2.39M
% TURNOVER1.93%
TURNOVER--
P/E (TTM)-0.1233
% RANGE12.84%
EPS(TTM)-2.0936
P/E(FORWARD)-0.1324
P/B-1.0522
BVPS-0.2454
DIVIDEND--
P/S52.69
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP13.33M
SHARES OUTSTANDING246.36M
NEXT EARNINGS05/12-05/16
FREE FLOAT51.62M
LOT SIZE1
EX-DIV DATE12/18/2023
News
Press Releases
Financial Reports
Profile
Benzinga·16h ago
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
NASDAQ·1d ago
Tuesday Sector Leaders: Cigarettes & Tobacco, Drugs
Benzinga·1d ago
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga·5d ago
12 Health Care Stocks Moving In Friday's Intraday Session
Seeking Alpha·5d ago
Cyclacel Pharmaceuticals declares $0.15 dividend
TipRanks·04/03 03:54
Cyclacel Pharmaceuticals Shifts Focus to Cancer Drug Development
Press release·04/02 22:20
Cyclacel Pharmaceuticals, Inc. (CYCC) Annual Report (Form 10-K) for the fiscal year ended December 31, 2024
TipRanks·04/02 20:59
Cyclacel Pharmaceuticals Appoints New Directors Amid Strategic Shift
Seeking Alpha·04/02 20:24
Cyclacel Pharmaceuticals GAAP EPS of -$0.33
Same Industry
Name/Symbol
Change%
Price
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.